Sepsis — Clinical Documentation Guide (2026)

🔍 1. Definition

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. The modern Sepsis-3 consensus definition, published in JAMA (2016) and reinforced by the 2026 Surviving Sepsis Campaign (SSC) Guidelines, defines sepsis as suspected or confirmed infection plus acute organ dysfunction, operationalized as a Sequential Organ Failure Assessment (SOFA) score increase of ≥ 2 points from baseline.

Septic shock is a subset of sepsis with profound circulatory, cellular, and metabolic abnormalities: vasopressor requirement to maintain mean arterial pressure (MAP) ≥ 65 mmHg and serum lactate > 2 mmol/L (18 mg/dL) despite adequate fluid resuscitation, associated with in-hospital mortality exceeding 40%.

For ICD-10-CM coding and CMS reimbursement purposes, facilities continue to apply the older Sepsis-2/SIRS framework alongside Sepsis-3 because the ICD-10-CM FY2026 Official Guidelines (Section I.C.1.d) and the code set itself still reference systemic inflammatory response syndrome (SIRS), severe sepsis (R65.20/R65.21), and septic shock terminology. Documentation must explicitly state sepsis — SIRS criteria alone are insufficient for code assignment per guideline I.A.19.

🗂️ 2. Alternative Terminology

The clinical and documentation landscape for sepsis includes multiple synonymous, near-synonymous, and outdated terms. Understanding these is critical for CDI and coders who must reconcile physician notes, nursing documentation, and discharge summaries.

🩺 3. Signs & Symptoms

Sepsis presents with a spectrum of findings reflecting the underlying infection and the systemic inflammatory response. The qSOFA (quick SOFA) score provides a rapid bedside screening tool, while the full SOFA score quantifies organ dysfunction.

qSOFA criteria (1 point each; score ≥ 2 suggests poor outcome in infection):

• Respiratory rate ≥ 22 breaths/minute
• Systolic blood pressure ≤ 100 mmHg
• Altered mental status (GCS < 15)

Additional clinical signs often documented:

• Fever (> 38.3°C / 101°F) or hypothermia (< 36°C / 96.8°F)
• Tachycardia (heart rate > 90 bpm)
• Leukocytosis (WBC > 12,000/μL) or leukopenia (WBC < 4,000/μL)
• Elevated serum lactate (> 2 mmol/L indicates tissue hypoperfusion)
• Hypotension (MAP < 65 mmHg) — hallmark of septic shock
• Oliguria (urine output < 0.5 mL/kg/hr for > 2 hours)
• Elevated creatinine, bilirubin, or coagulation abnormalities
• Thrombocytopenia (platelets < 100,000/μL)
• Decreased capillary refill, mottling, cold extremities

SOFA score organ systems (score 0–4 per system; ≥ 2-point increase = organ dysfunction):

🧭 4. Differential Diagnosis

Several conditions mimic sepsis or can present simultaneously with sepsis, creating documentation and coding challenges. CDI specialists should ensure that the principal diagnosis is clearly documented as sepsis when it meets the definition, not a mimicking condition.

📋 5. Clinical Indicators for Coders/CDI

CDI specialists should scan for the following clinical indicators in the medical record to identify potential documentation gaps and trigger appropriate queries before final coding.

🦴 6. Anatomy & Pathophysiology

Sepsis arises when a localized infection overwhelms host containment mechanisms, triggering a systemic cascade. The pathophysiology involves three interconnected processes:

1. Infection and Pattern Recognition: Bacterial, fungal, viral, or parasitic pathogens release pathogen-associated molecular patterns (PAMPs — e.g., lipopolysaccharide, peptidoglycan) recognized by innate immune receptors (TLR-4 for LPS). Host cell damage releases damage-associated molecular patterns (DAMPs). This activates macrophages, neutrophils, and endothelial cells.

2. Dysregulated Inflammatory Response: Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) are released, triggering systemic vasodilation, increased vascular permeability, and coagulation activation. In sepsis, this response is excessive and maladaptive — the host response causes collateral damage to organs. Simultaneously, anti-inflammatory cytokines (IL-10) lead to immune suppression and immunoparalysis, increasing susceptibility to secondary infections.

3. Microvascular Dysfunction and Organ Failure: Endothelial injury leads to capillary leak, third-spacing of fluids, and distributive shock. Microthrombi from coagulopathy compromise end-organ perfusion. Mitochondrial dysfunction impairs cellular oxygen utilization (cytopathic hypoxia). Organs fail in a progressive cascade: lungs (ARDS), kidneys (AKI), liver (hepatic dysfunction), brain (septic encephalopathy), and coagulation system (DIC).

The lung is typically the first organ to fail, presenting as acute respiratory distress syndrome (ARDS), coded as J80 and representing an important organ dysfunction code when documenting severe sepsis.

💊 7. Medication Impact / Treatment

The 2026 Surviving Sepsis Campaign Guidelines outline evidence-based pharmacologic interventions with direct coding and documentation implications:

Antimicrobials: For septic shock or probable/definite sepsis, guidelines recommend administration within 1 hour of recognition (strong recommendation). For possible sepsis without shock, within 3 hours. Early, appropriate antibiotic therapy must be documented to support the diagnosis in coding. The specific antimicrobial used supports organism-specific coding (e.g., vancomycin/linezolid suggests MRSA; piperacillin-tazobactam suggests gram-negative coverage).

Vasopressors: Norepinephrine is first-line vasopressor in septic shock (strong recommendation per 2026 SSC). Vasopressin may be added for escalating norepinephrine doses. The use of vasopressors is a key clinical indicator for septic shock documentation. Norepinephrine is billed under HCPCS J3490 (unclassified drug, no dedicated J-code for generic norepinephrine bitartrate in most formularies) or facility-specific drug codes.

Corticosteroids: IV hydrocortisone 200–300 mg/day is recommended in septic shock unresponsive to adequate fluid/vasopressor therapy. Steroid use does not independently affect sepsis coding but should be noted in the patient record as evidence of refractory septic shock.

Fluid Resuscitation: At least 30 mL/kg IV crystalloid (balanced crystalloids preferred over normal saline per 2026 SSC) in the first 3 hours. Albumin may be appropriate after large crystalloid volumes. Avoiding hydroxyethyl starch (strongly recommended against). Fluid administration is part of the sepsis order set and supports clinical indicator documentation.

Insulin Therapy: Glucose management targeting < 180 mg/dL in ICU patients with sepsis. When insulin drip is initiated, document hyperglycemia or diabetes as comorbidity codes.

Mechanical Ventilation (Lung Protective): For ARDS complicating sepsis: tidal volume 6 mL/kg predicted body weight, plateau pressure ≤ 30 cmH₂O. CPT codes 94002–94003 apply for initiation of invasive ventilation; duration determines DRG (870 if > 96 hours continuous).

Documentation Alert — Drug Therapy Links to Organ Dysfunction: Vasopressor initiation → document septic shock (R65.21). Mechanical ventilation → document acute respiratory failure (J96.0x) and if > 96 hrs consider DRG 870. Renal replacement therapy → document acute kidney injury (N17.x) as organ dysfunction under severe sepsis.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO CDG members.

📘 8. ICD-10-CM Guidelines (FY2026)

Sepsis coding is governed by ICD-10-CM FY2026 Official Guidelines Section I.C.1.d — “Sepsis, Severe Sepsis, and Septic Shock.” These rules are among the most complex in the entire code set and are frequent targets for compliance audits.

I.C.1.d.1 — Coding of Sepsis (Basic)

• Assign a code for the underlying systemic infection first (A40.x, A41.x, etc.).
• If the causal organism is not specified, assign A41.9 (Sepsis, unspecified organism).
• Do not assign additional codes from R65.1- (SIRS) as a secondary code when the provider has documented sepsis.
• Sepsis cannot be coded from SIRS criteria alone — explicit physician documentation is required (Guideline I.A.19).

I.C.1.d.1.b — Severe Sepsis

• Severe sepsis requires a minimum of two codes: the underlying infection code (A40.x, A41.x) AND R65.20 or R65.21.
• Additional codes for each associated acute organ dysfunction (AKI, ARDS, hepatic failure, etc.) should also be assigned.
• R65.20 = Severe sepsis without septic shock; R65.21 = Severe sepsis with septic shock.
• R65.21 (septic shock) can never be sequenced as the principal diagnosis.

I.C.1.d.1.a — Sepsis + Localized Infection (Pneumonia, UTI, Cellulitis)

• When the reason for admission is sepsis or severe sepsis AND a localized infection: code the underlying systemic infection (sepsis) first, then the localized infection as secondary.
• Exception: If the patient was admitted for the localized infection and sepsis/severe sepsis developed after admission, sequence the localized infection as principal, followed by the sepsis codes.
• Example: Patient admitted with sepsis from pneumonia → A41.9 (principal), J18.9 (secondary), R65.20 or R65.21 if severe sepsis present.

I.C.1.d.3 — Septic Shock

• Septic shock always indicates severe sepsis — always assign R65.21 (not R65.20).
• Sequence: (1) systemic infection code, (2) R65.21, (3) codes for any acute organ dysfunction.
• For post-procedural septic shock: code T81.12- (postprocedural septic shock) first, not R65.21.

I.C.1.d.5 — Sepsis Due to Postprocedural Infection

• When a procedure is complicated by sepsis: assign the appropriate complication code (e.g., T81.44x Sepsis following a procedure) as the principal diagnosis.
• Additional codes: the specific infection/organism and R65.2- if severe sepsis present.
• Central line-associated bloodstream infection (CLABSI): T80.211- (infection due to central venous catheter) sequenced first.

I.C.1.d.6 — Sepsis from Non-Infectious Process (e.g., Trauma, Burns)

• When a non-infectious condition (trauma, burn) leads to sepsis: if the non-infectious condition meets the definition of principal diagnosis, sequence it first, followed by the infection code and sepsis codes.

I.C.15.j — Sepsis in Pregnancy / Puerperal (Chapter 15)

• Puerperal sepsis (O85) or sepsis complicating other obstetric conditions: sequence the obstetric sepsis code first (O85, O75.3, etc.), then the infection type code.
• Assign R65.2- for severe sepsis if documented.

Neonatal Sepsis — P36.x (Chapter 16)

• Neonatal sepsis codes (P36.x) are used only for the newborn period and are found in Chapter 16 (Perinatal conditions).
• Do not assign A40/A41 for neonatal sepsis — use P36.0 through P36.9 with the specific organism when documented.

🔢 9. ICD-10-CM Code Set (FY2026)

The following table covers the primary sepsis codes effective October 1, 2025 through September 30, 2026, per the ICD-10-CM FY2026 Tabular List (CMS).

🔎 10. Indexing

Correct use of the ICD-10-CM Alphabetic Index is essential for sepsis coding accuracy:

• Sepsis — main term in Index; sub-terms by organism (e.g., “Sepsis, due to, Escherichia coli” → A41.51)
• Septicemia — cross-references to Sepsis in FY2026 Index (no longer a separate main term)
• Urosepsis — Index states “code to condition” — do not assign sepsis code without physician documentation
• Sepsis syndrome — not indexed; query provider
• Severe sepsis → R65.20 (Index entry: “Sepsis, severe, without septic shock”) or R65.21 (“with septic shock”)
• Septic shock — secondary code only; Index notes R65.21 as additional code with underlying sepsis code first
• Bacteremia → R78.81 (when no sepsis documented); Index: “Bacteremia, see Sepsis” when sepsis is documented
• SIRS (infectious) → see Sepsis; SIRS of non-infectious origin → R65.10/R65.11
• Blood poisoning — lay term; Index → See Sepsis
• Childbed fever — lay term for puerperal sepsis → O85

🏥 11. CPT (2026)

Physician procedural coding for sepsis management primarily involves evaluation and management (E/M) critical care codes and procedural codes for interventions performed during sepsis care. All codes effective for CY2026 per the AMA CPT 2026 code set.

🧾 12. HCPCS (2026)

HCPCS Level II codes relevant to sepsis management primarily cover drugs administered during inpatient care and, in outpatient/observation settings, infusion therapy. Per CMS HCPCS 2026, vasopressors commonly used in septic shock do not have dedicated J-codes for all formulations and are often billed as unclassified or facility-specific line items in the inpatient DRG setting.

Note: Inpatient hospital billing for drugs under DRG is typically bundled into the DRG payment. Separate HCPCS drug billing applies primarily in outpatient, ED, and observation encounters. J3490 (unclassified) requires documentation of the drug name, dose, and route in the medical record for claims processing.

📚 13. AHA Coding Clinic (Recent Guidance)

The following AHA Coding Clinic references provide authoritative guidance on sepsis coding scenarios. Coders and CDI specialists should reference these for complex cases:

💰 14. HCC / Risk Adjustment (v28)

Under the CMS-HCC Model V28, fully operative for payment year 2026 (100% V28; phased implementation complete), sepsis maps to HCC 2 — Septicemia, Sepsis, SIRS/Shock.

*The exact V28 coefficient for HCC 2 is approximately 0.474 for the Community, NonDual, Aged segment based on CMS regression analysis. The CMS 2027 Advance Notice proposes a +15.6% increase to the HCC 2 coefficient, reflecting that sepsis and septic shock represent acute, high-cost clinical events warranting higher reimbursement weights under the proposed 2027 model.

Risk Adjustment / RADV Audit Implications: HCC 2 is one of the highest-scrutiny categories in OIG and CMS Risk Adjustment Data Validation (RADV) audits, precisely because its coefficient is high. The medical record must substantiate the sepsis diagnosis with explicit physician documentation (not SIRS criteria alone) and clinical indicators (positive cultures, organ dysfunction, treatment with antibiotics and/or vasopressors). Coding from laboratory results alone without physician documentation does not support RAF capture.

✍️ 15. CDI Query Templates

All query templates below are designed to be compliant with AHIMA/ACDIS CDI Query Practice Guidelines — non-leading, multiple choice, with a clinically undetermined option. Facility-specific query platforms may require formatting adaptation.

🧑‍⚕️ 16. Treatments (Clinical)

This section summarizes the evidence-based clinical treatment framework for sepsis per the 2026 Surviving Sepsis Campaign International Guidelines. Understanding treatment patterns helps CDI specialists identify documentation opportunities.

The “Sepsis Bundle” (SSC Hour-1 Bundle):

• Measure lactate level; re-measure if initial lactate > 2 mmol/L
• Obtain blood cultures before administering antibiotics
• Administer broad-spectrum antibiotics immediately (within 1 hour for shock, within 1–3 hours for sepsis without shock)
• Administer 30 mL/kg crystalloid for hypotension or lactate ≥ 4 mmol/L
• Apply vasopressors for hypotension unresponsive to fluids — maintain MAP ≥ 65 mmHg

Source Control: Identify and control the infection source — percutaneous drainage of abscess, removal of infected catheter, surgical debridement, etc. Source control documentation supports organism-specific codes and localized infection as secondary diagnosis.

Resuscitation Monitoring: Serial lactate measurements to guide resuscitation. Passive leg raise or fluid challenge to assess fluid responsiveness (dynamic over static measures per 2026 SSC). Invasive blood pressure monitoring for hemodynamically unstable patients on vasopressors.

Antimicrobial De-escalation: Reassess empiric antibiotics at 48–72 hours based on culture results. De-escalation to organism-specific narrow therapy reduces resistance. Final antibiotic selection often confirms the specific organism code (e.g., confirmed E. coli → A41.51 instead of A41.9).

Organ Support:

• Respiratory: Lung-protective ventilation for ARDS (LTVV 6 mL/kg IBW, PEEP ≥ 5, plateau pressure ≤ 30 cmH₂O); prone positioning for severe ARDS (PaO₂/FiO₂ < 150)
• Renal: Continuous renal replacement therapy (CRRT) or intermittent hemodialysis for sepsis-associated AKI — code N17.x plus dialysis procedure codes
• Glycemic Control: Target blood glucose < 180 mg/dL; insulin infusion protocol
• Stress Ulcer Prophylaxis: PPI or H2 blocker in ICU patients on vasopressors or mechanical ventilation
• VTE Prophylaxis: LMWH preferred unless contraindicated; mechanical prophylaxis if pharmacological contraindicated

Corticosteroids: IV hydrocortisone 200 mg/day (continuous infusion or 50 mg q6h) for septic shock unresponsive to adequate fluids and vasopressors. Taper when vasopressors are weaned.

Emerging Therapies: Immunomodulatory agents (e.g., IL-6 inhibitors in sepsis with specific cytokine profiles) are under active investigation but not yet standard of care per current SSC guidelines.

🎓 17. Patient Education / Summary

The following summary is written in plain language for patient and family education. CDI specialists and discharge planners may adapt this for discharge instructions, hospital fact sheets, or population health materials.

What Is Sepsis?
Sepsis is a serious medical emergency that happens when your body’s response to an infection gets out of control and starts damaging your own tissues and organs. It can develop from any infection — a lung infection (pneumonia), a urinary tract infection, an infected wound, or even an infection you do not know you have. Sepsis is not contagious; it develops within the person who has the infection.

Why Is It an Emergency?
Sepsis can progress quickly to septic shock — a life-threatening condition where blood pressure drops dangerously and organs begin to fail. Every hour of delay in treatment increases the risk of death. Sepsis is one of the leading causes of death in hospitals worldwide, but early treatment significantly improves outcomes.

Warning Signs — When to Seek Emergency Care:

• High fever (above 101°F / 38.3°C) or unusually low temperature (below 96.8°F)
• Rapid heart rate (more than 90 beats per minute)
• Rapid breathing (more than 22 breaths per minute)
• Confusion, disorientation, or extreme sleepiness
• Skin that looks mottled, pale, or feels very cold
• Decreased urination
• Extreme pain or discomfort described as “the worst I’ve ever felt”

Treatment:
Treatment for sepsis always takes place in the hospital, usually in the ICU. Doctors will give intravenous (IV) antibiotics immediately, provide IV fluids, and may need to use medications to maintain blood pressure (vasopressors). Some patients need a breathing machine (ventilator) to help their lungs. Treatment also focuses on finding and treating the source of the infection (for example, draining an abscess or removing an infected device).

Recovery and Long-Term Effects:
Recovery from sepsis can take weeks to months. Some survivors experience “post-sepsis syndrome” — ongoing fatigue, difficulty concentrating (“brain fog”), joint pain, and increased susceptibility to other infections. Rehab programs, follow-up care, and patient support organizations like the Sepsis Alliance can help with recovery.

Prevention:

• Stay current on vaccinations (flu, pneumococcal, COVID-19) — these prevent infections that can lead to sepsis
• Wash hands frequently
• Manage chronic conditions (diabetes, kidney disease) that increase sepsis risk
• Seek medical care promptly for infections that worsen or do not improve
• Follow wound care instructions after surgery or injury

About this Guide

This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2026 ICD-10-CM (effective October 1, 2025). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.

Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)